EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The mitochondria-targeting compound PTC299 enhances megakaryocyte and platelet production

Xiaoli Wang, Meijuan Xia, Yifei Cai, Ziqi Huo, Yao Zhong, Pei Su, Cuicui Liu, Hongtao Wang, Xiangchun Shen, Fei Wang, Jianwei Xu, Jiaxi Zhou iD

Stem Cells Translational Medicine · 18.05.2026 · 15 (7)

DOI: 10.1093/stcltm/szag035 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Stem Cells Translational Medicine, online erschienen am 27.06.2026. Verfasst von Xiaoli Wang und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Guizhou Medical University, Gui'an New District, Guiyang 561113, China. Hauptthemen laut MEDLINE: Megakaryocytes, Blood Platelets, Mitochondria, Thrombocytopenia. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Innovative Drug Research and Development National Science and Technology Major Project, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Backgroud: Thrombocytopenia is a common complication of various clinical conditions, resulting from impaired megakaryocyte function, reduced platelet production, or excessive platelet destruction. Current treatments, including platelet transfusions and thrombopoietin receptor agonists, are limited by platelet supply constraints and risks such as thrombotic complications. Emerging research highlights the role of mitochondrial-related biological processes or components in thrombopoiesis, yet targeted therapeutics remain scarce.

Methods

In this study, we investigated mitochondria-targeted compounds for their potential to enhance megakaryocyte and platelet productionusing a fetal liver megakaryocyte differentiation and platelet culture system, and explored their effects on in vivo megakaryocyte and platelet production using a radiation damage-induced thrombocytopenia mouse model.

Results

Our findings identify PTC299, a dihydroorotate dehydrogenase and VEGFA mRNA translation inhibitor, as a promising pro-plateletogenic agent. PTC299 not only enhances megakaryocyte and platelet production in vitro but also accelerates their recovery in a mouse model of radiation-induced thrombocytopenia. Additionally, PTC299 alleviates irradiation-induced splenomegaly.

Conclusion

PTC299 promotes megakaryocyte differentiation and platelet generation both in vitro and in vivo, demonstrating potential values for thrombocytopenia treatment and platelet regeneration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MegakaryocytesBlood PlateletsMitochondriaThrombocytopeniaThrombopoiesisAnimalsMiceCell DifferentiationHumansMice, Inbred C57BL

Stichwörter der Autor:innen

DHODHPTC299megakaryocytemitochondriaplateletsthrombocytopenia

Autor:innen und Institutionen

  • School of Pharmacy, Guizhou Medical University, Gui'an New District, Guiyang 561113, China.
  • State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sc…
  • Tianjin Institutes of Health Science, Tianjin 301600, China.
  • Center for Tissue Engineering and Stem Cell Research, Guizhou Medical University, Gui'an New District, Guiyang 561113, China.
  • HaemoCure Inc, Tianjin 300459, China.

ORCID-Profile: Jiaxi Zhou

Förderung

  • Innovative Drug Research and Development National Science and Technology Major Project
  • National Natural Science Foundation of China

Zitieren

APA

Wang, X., Xia, M., Cai, Y., Huo, Z., Zhong, Y., Su, P., Liu, C., Wang, H., Shen, X., Wang, F., Xu, J., & Zhou, J. (2026). The mitochondria-targeting compound PTC299 enhances megakaryocyte and platelet production. Stem Cells Translational Medicine, 15(7). https://doi.org/10.1093/stcltm/szag035

Vancouver

Wang X, Xia M, Cai Y, Huo Z, Zhong Y, Su P, et al. The mitochondria-targeting compound PTC299 enhances megakaryocyte and platelet production. Stem Cells Translational Medicine. 2026;15(7). doi:10.1093/stcltm/szag035

BibTeX
@article{Wang2026,
  author = {Wang, Xiaoli and Xia, Meijuan and Cai, Yifei and Huo, Ziqi and Zhong, Yao and Su, Pei and Liu, Cuicui and Wang, Hongtao and Shen, Xiangchun and Wang, Fei and Xu, Jianwei and Zhou, Jiaxi},
  title = {The mitochondria-targeting compound PTC299 enhances megakaryocyte and platelet production},
  journal = {Stem Cells Translational Medicine},
  year = {2026},
  volume = {15},
  number = {7},
  doi = {10.1093/stcltm/szag035}
}
Kostenlos starten →